Will better-tolerated antihypertensive agents improve blood pressure control? JNC VI revisited

American Journal of Hypertension

Volumn 12, Issue 12 SUPPL. 1, 1999, Pages 225-230

  Black, Henry R ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adherence; Adverse reactions; Guidelines; Prevention

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RENIN; SARALASIN;

ANGIONEUROTIC EDEMA; BLOOD PRESSURE; CLINICAL TRIAL; COUGHING; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; STROKE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; PATIENT COMPLIANCE; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 0033401826     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(99)00102-8     Document Type: Article

References (18)

1. Burt VL, Cutler JA, Higgins M, et al: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-69.
2. The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The sixth report. Arch Intern Med 1997;157:2413-2446.
3. Barker WH, Mullooly JP, Linton KL: Trends in hypertension prevalence, treatment, and control: in a well-defined older population. Hypertension 1998;31:552559.
4. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents: Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents. Pediatrics 1996;98:649-658.
5. Appel LJ, Stason WB: Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med 1993;118:867-882.
6. Hansson L, Zanchetti A, Carruthers SG, et al: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-1762.
7. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998;317:703-713.
8. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report. Arch Intern Med 1993;153:154-183.
9. National High Blood Pressure Education Program Working Group: Report on hypertension in the elderly. Hypertension 1994;23:275-285.
10. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
11. Staessen JA, Fagard R, Thijs L, et al: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-764.
12. Pitt B, Segal R, Martinez FA, et al: Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-752.
13. Australia/New Zealand Heart Failure Research Collaborative Group: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 1997;349:375-380.
14. Setaro JF, Black HR: Refractory hypertension. N Engl J Med 1992;327:543-547.
15. Black HR: Fixed-dose combination therapy for hypertension. Patient Care May 1997;13-20.
16. Cushman WC, Black HR, Probsfield J, et al: Blood Pressure Control in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Presented at the 13th Scientific Meeting of the American Society of Hypertension, May 13-16, 1998. Am J Hypertens 1998;11:17A.
17. Black HR, Crocitto MT: Number needed to treat: solid science or a path to pernicious rationing? Am J Hypertens 1998;11:128S-134S.
18. Vita AJ, Terry RB, Hubert HB, Fries JF: Aging, health risks, and cumulative disability. N Engl J Med 1998; 338:1035-1041.